Found: 4
Select item for more details and to access through your institution.
Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 9, p. 1266, doi. 10.3390/ph16091266
- By:
- Publication type:
- Article
An overview of cdc2‐like kinase 1 (Clk1) inhibitors and their therapeutic indications.
- Published in:
- Medicinal Research Reviews, 2023, v. 43, n. 2, p. 343, doi. 10.1002/med.21928
- By:
- Publication type:
- Article
5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency.
- Published in:
- Molecules, 2021, v. 26, n. 4, p. 1001, doi. 10.3390/molecules26041001
- By:
- Publication type:
- Article
Structure-Based Design of Novel Tetrahydro-Beta-Carboline Derivatives with a Hydrophilic Side Chain as Potential Phosphodiesterase Inhibitors.
- Published in:
- Scientia Pharmaceutica, 2016, v. 84, n. 3, p. 428, doi. 10.3390/scipharm84030428
- By:
- Publication type:
- Article